Crestline Management, L.P. holds a concentrated book of 3 stocks worth $53.5M as of Q2 2026 (disclosed Aug 14, 2026, a ~45-day 13F lag). This quarter they trimmed Denali Therapeutics Inc. Their largest long position is Denali Therapeutics Inc at 92% of the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
No buys this quarter.
Other tracked managers holding the same core names as Crestline Management, L.P.
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BlackRock, Inc. | 3 / 3 | $311.1M |
| STATE STREET CORP | 3 / 3 | $225.2M |
| FMR LLC | 3 / 3 | $198.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3 / 3 | $149.0M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3 / 3 | $134.3M |
| GEODE CAPITAL MANAGEMENT, LLC | 3 / 3 | $124.8M |
| GOLDMAN SACHS GROUP INC | 3 / 3 | $95.9M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | 3 / 3 | $85.8M |
Ranked by how many of Crestline Management, L.P.'s top 3 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Denali Therapeutics Inc COM | $49.1M | 1.91M | 91.9% | ▼−14% Reduced · −300K sh | |
| 2 | Sana Biotechnology Inc COM | $2.6M | 755.7K | 4.9% | —Held | |
| 3 | 8X8 Inc New COM | $1.7M | 990.9K | 3.2% | —Held |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1536054/holdings"
Use Arkolith to show Crestline Management, L.P.'s latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 14, 2026 | 3 | $53.5M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 3 | $46.3M | 13F-HR/A |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 3 | $53.3M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.